Literature DB >> 12967513

The challenge of following process, damage, and function in patients with rheumatoid arthritis in clinical care.

Josef S Smolen1, Daniel Aletaha.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12967513     DOI: 10.1007/s11926-003-0014-8

Source DB:  PubMed          Journal:  Curr Rheumatol Rep        ISSN: 1523-3774            Impact factor:   4.592


× No keyword cloud information.
  66 in total

1.  Infliximab and methotrexate in the treatment of rheumatoid arthritis. Anti-Tumor Necrosis Factor Trial in Rheumatoid Arthritis with Concomitant Therapy Study Group.

Authors:  P E Lipsky; D M van der Heijde; E W St Clair; D E Furst; F C Breedveld; J R Kalden; J S Smolen; M Weisman; P Emery; M Feldmann; G R Harriman; R N Maini
Journal:  N Engl J Med       Date:  2000-11-30       Impact factor: 91.245

2.  Clinical improvement and radiological deterioration in rheumatoid arthritis: evidence that the pathogenesis of synovial inflammation and articular erosion may differ.

Authors:  D Mulherin; O Fitzgerald; B Bresnihan
Journal:  Br J Rheumatol       Date:  1996-12

3.  A simple algorithm to predict the development of radiological erosions in patients with early rheumatoid arthritis: prospective cohort study.

Authors:  P Brennan; B Harrison; E Barrett; K Chakravarty; D Scott; A Silman; D Symmons
Journal:  BMJ       Date:  1996-08-24

4.  "Are you better?" A qualitative study of the meaning of recovery.

Authors:  D E Beaton; V Tarasuk; J N Katz; J G Wright; C Bombardier
Journal:  Arthritis Rheum       Date:  2001-06

Review 5.  Role of cytokines in rheumatoid arthritis.

Authors:  M Feldmann; F M Brennan; R N Maini
Journal:  Annu Rev Immunol       Date:  1996       Impact factor: 28.527

6.  Patterns of radiological progression in early rheumatoid arthritis: results of an 8 year prospective study.

Authors:  M J Plant; P W Jones; J Saklatvala; W E Ollier; P T Dawes
Journal:  J Rheumatol       Date:  1998-03       Impact factor: 4.666

Review 7.  The links between joint damage and disability in rheumatoid arthritis.

Authors:  D L Scott; K Pugner; K Kaarela; D V Doyle; A Woolf; J Holmes; K Hieke
Journal:  Rheumatology (Oxford)       Date:  2000-02       Impact factor: 7.580

8.  A simplified disease activity index for rheumatoid arthritis for use in clinical practice.

Authors:  J S Smolen; F C Breedveld; M H Schiff; J R Kalden; P Emery; G Eberl; P L van Riel; P Tugwell
Journal:  Rheumatology (Oxford)       Date:  2003-02       Impact factor: 7.580

9.  Efficacy and safety of leflunomide compared with placebo and sulphasalazine in active rheumatoid arthritis: a double-blind, randomised, multicentre trial. European Leflunomide Study Group.

Authors:  J S Smolen; J R Kalden; D L Scott; B Rozman; T K Kvien; A Larsen; I Loew-Friedrich; C Oed; R Rosenburg
Journal:  Lancet       Date:  1999-01-23       Impact factor: 79.321

10.  Concordance between clinician and patient assessment of physical and mental health status.

Authors:  C K Kwoh; G T O'Connor; M G Regan-Smith; E M Olmstead; L A Brown; J B Burnett; R F Hochman; K King; G J Morgan
Journal:  J Rheumatol       Date:  1992-07       Impact factor: 4.666

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.